Shopping Cart 0
Cart Subtotal
USD 0

Washington University School of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750

Details

Summary

Washington University School of Medicine (WUSTL), a subsidiary of University of Washington is a medical university that offers patient care, research, education services and neurology clinical trials. The university provides patient care services such as clinical, find a doctor, referring physicians and others. Its research program comprise post doctoral research opportunities, research labs, knight ADRC, hope center, MS center, infantile spasms, regional, synaptic, and others. The university conducts neurology clinical trials such as headaches, multiple sclerosis and stroke, brain, spinal cord and nervous system, behavior and performance unit, aging, and sleep disorders, among others. It operates through four campus located in St. Louis, the US. Washington University is headquartered in St. Louis, Missouri, the US.

Washington University School of Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Washington University School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Washington University School of Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine 12

Mallinckrodt Enters into Research Partnership with Washington University 13

Cerveau Technologies Enters into Agreement with Washington University School of Medicine 14

MedImmune Enters into Agreement with Washington University School of Medicine 15

LEO Pharma Enters into Agreement with Washington University School of Medicine 16

Licensing Agreements 17

Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 17

Washington University School of Medicine-Key Competitors 18

Washington University School of Medicine-Key Employees 19

Washington University School of Medicine-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Government and Public Interest 21

Aug 23, 2018: Natural sugar defends against metabolic syndrome, in mice 21

Aug 22, 2018: Study finds nerve stimulation can help depression patients 22

Aug 21, 2018: Depressed patients see quality of life improve with nerve stimulation 23

Aug 16, 2018: New approach to developing antidepressants 25

Aug 08, 2018: Brain tumors occur often in kids with common genetic syndrome 27

Aug 06, 2018: Mallinckrodt boosts rare-disease research at Washington University 28

Jul 05, 2018: Gene therapy method developed to target damaged kidney cells 29

Jun 27, 2018: LSU Pennington Biomedical Research Center Approved for USD 4.5 Million for Study on Childhood Obesity Treatment 30

Jun 26, 2018: Chemotherapy-induced diarrhea traced to immune cells 32

Jun 07, 2018: Genes linked to Alzheimer's contribute to damage in different ways 33

Jun 07, 2018: Scientists ID source of damaging inflammation after heart attack 34

Jun 07, 2018: Siteman Cancer Center among leading institutions encouraging HPV vaccination 36

Jun 01, 2018: Immunosuppressant drugs may protect against Parkinson's 37

May 31, 2018: Drugs that suppress immune system may protect against Parkinson's 38

May 29, 2018: Brain cancer vaccine effective in some patients 39

May 17, 2018: Blood type affects severity of diarrhea caused by E. coli 40

May 10, 2018: USD 5 million supports innovative breast cancer trial 42

Apr 24, 2018: Experimental arthritis drug prevents stem cell transplant complication 43

Apr 17, 2018: New clues point to relief for chronic itching 44

Apr 05, 2018: Macular degeneration linked to aging immune cells 45

Mar 29, 2018: CRISPR enhances gene therapy to fight inherited diseases 46

Mar 27, 2018: Drug compound shows promise against rheumatoid arthritis 48

Mar 27, 2018: Antibiotic use increases risk of severe viral disease in mice 49

Mar 26, 2018: Antibody removes Alzheimer's plaques, in mice 51

Mar 05, 2018: CRISPR enhances cancer immunotherapy 52

Jan 24, 2018: Light-triggered nanoparticles show promise against metastatic cancer 53

Dec 06, 2017: Clot-busting drugs not recommended for most patients with blood clots 54

Nov 06, 2017: USD 6 million supports leukemia research 56

Nov 02, 2017: In autism, too many brain connections may be at root of condition 57

Oct 18, 2017: New gene-altering treatment offered for certain blood cancers 59

Oct 18, 2017: New gene-altering treatment offered for blood cancers 61

Sep 25, 2017: Chemo-loaded nanoparticles target breast cancer that has spread to bone 63

Sep 05, 2017: Zika virus shrinks brain tumours in lab tests 64

Sep 05, 2017: Zika virus selectively infects and kills glioblastoma cells in mice 65

Jul 13, 2017: Experimental Zika Virus Vaccines Restrict In Utero Virus Transmission in Mice 66

Jun 14, 2017: UTI treatment reduces E. coli, may offer alternative to antibiotics 67

Jun 07, 2017: Nation's Largest Suicide Prevention Organization Awards USD 1Million Research Grant to Researcher in St. Louis 69

May 23, 2017: Maher receives American Cancer Society Research Scholar Grant 70

Apr 27, 2017: Scientists at Shriners Hospitals for Children re-wire cells to produce arthritis vaccine 71

Apr 19, 2017: Antibody helps detect protein implicated in Alzheimer's, other diseases 72

Apr 04, 2017: USD 3.6 million to fund personalised 3D brain maps to guide neurosurgeries 74

Jan 24, 2017: Study unveils new way to starve tumors to death 76

Product News 78

Dec 06, 2017: Alzheimer's damage in mice reduced with compound that targets APOE gene 78

Jun 19, 2018: Decades of dedication lead to drug trial for rare, fatal illness 79

Other Significant Developments 82

Sep 04, 2018: Focused delivery for brain cancers 82

Jun 19, 2018: Parent-child therapy helps young children with depression 84

Appendix 85

Methodology 85

About GlobalData 85

Contact Us 85

Disclaimer 85


List Of Figure

List of Figures

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Washington University School of Medicine, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Washington University School of Medicine, Pharmaceuticals & Healthcare, Key Facts 2

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Washington University School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Washington University School of Medicine, Deals By Therapy Area, 2012 to YTD 2018 9

Washington University School of Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine 12

Mallinckrodt Enters into Research Partnership with Washington University 13

Cerveau Technologies Enters into Agreement with Washington University School of Medicine 14

MedImmune Enters into Agreement with Washington University School of Medicine 15

LEO Pharma Enters into Agreement with Washington University School of Medicine 16

Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 17

Washington University School of Medicine, Key Competitors 18

Washington University School of Medicine, Key Employees 19

Washington University School of Medicine, Subsidiaries 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Washington University School of Medicine, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Washington University School of Medicine (WUSTL), a subsidiary of University of Washington is a medical university that offers patient care, research, education services and neurology clinical trials. The university provides patient care services such as clinical, find a doctor, referring physicians and others. Its research program comprise post doctoral research opportunities, research labs, knight ADRC, hope center, MS center, infantile spasms, regional, synaptic, and others. The university conducts neurology clinical trials such as headaches, multiple sclerosis and stroke, brain, spinal cord and nervous system, behavior and performance unit, aging, and sleep disorders, among others. It operates through four campus located in St. Louis, the US. Washington University is headquartered in St. Louis, Missouri, the US.

Washington University School of Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Washington University School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Washington University School of Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine 12

Mallinckrodt Enters into Research Partnership with Washington University 13

Cerveau Technologies Enters into Agreement with Washington University School of Medicine 14

MedImmune Enters into Agreement with Washington University School of Medicine 15

LEO Pharma Enters into Agreement with Washington University School of Medicine 16

Licensing Agreements 17

Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 17

Washington University School of Medicine-Key Competitors 18

Washington University School of Medicine-Key Employees 19

Washington University School of Medicine-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Government and Public Interest 21

Aug 23, 2018: Natural sugar defends against metabolic syndrome, in mice 21

Aug 22, 2018: Study finds nerve stimulation can help depression patients 22

Aug 21, 2018: Depressed patients see quality of life improve with nerve stimulation 23

Aug 16, 2018: New approach to developing antidepressants 25

Aug 08, 2018: Brain tumors occur often in kids with common genetic syndrome 27

Aug 06, 2018: Mallinckrodt boosts rare-disease research at Washington University 28

Jul 05, 2018: Gene therapy method developed to target damaged kidney cells 29

Jun 27, 2018: LSU Pennington Biomedical Research Center Approved for USD 4.5 Million for Study on Childhood Obesity Treatment 30

Jun 26, 2018: Chemotherapy-induced diarrhea traced to immune cells 32

Jun 07, 2018: Genes linked to Alzheimer's contribute to damage in different ways 33

Jun 07, 2018: Scientists ID source of damaging inflammation after heart attack 34

Jun 07, 2018: Siteman Cancer Center among leading institutions encouraging HPV vaccination 36

Jun 01, 2018: Immunosuppressant drugs may protect against Parkinson's 37

May 31, 2018: Drugs that suppress immune system may protect against Parkinson's 38

May 29, 2018: Brain cancer vaccine effective in some patients 39

May 17, 2018: Blood type affects severity of diarrhea caused by E. coli 40

May 10, 2018: USD 5 million supports innovative breast cancer trial 42

Apr 24, 2018: Experimental arthritis drug prevents stem cell transplant complication 43

Apr 17, 2018: New clues point to relief for chronic itching 44

Apr 05, 2018: Macular degeneration linked to aging immune cells 45

Mar 29, 2018: CRISPR enhances gene therapy to fight inherited diseases 46

Mar 27, 2018: Drug compound shows promise against rheumatoid arthritis 48

Mar 27, 2018: Antibiotic use increases risk of severe viral disease in mice 49

Mar 26, 2018: Antibody removes Alzheimer's plaques, in mice 51

Mar 05, 2018: CRISPR enhances cancer immunotherapy 52

Jan 24, 2018: Light-triggered nanoparticles show promise against metastatic cancer 53

Dec 06, 2017: Clot-busting drugs not recommended for most patients with blood clots 54

Nov 06, 2017: USD 6 million supports leukemia research 56

Nov 02, 2017: In autism, too many brain connections may be at root of condition 57

Oct 18, 2017: New gene-altering treatment offered for certain blood cancers 59

Oct 18, 2017: New gene-altering treatment offered for blood cancers 61

Sep 25, 2017: Chemo-loaded nanoparticles target breast cancer that has spread to bone 63

Sep 05, 2017: Zika virus shrinks brain tumours in lab tests 64

Sep 05, 2017: Zika virus selectively infects and kills glioblastoma cells in mice 65

Jul 13, 2017: Experimental Zika Virus Vaccines Restrict In Utero Virus Transmission in Mice 66

Jun 14, 2017: UTI treatment reduces E. coli, may offer alternative to antibiotics 67

Jun 07, 2017: Nation's Largest Suicide Prevention Organization Awards USD 1Million Research Grant to Researcher in St. Louis 69

May 23, 2017: Maher receives American Cancer Society Research Scholar Grant 70

Apr 27, 2017: Scientists at Shriners Hospitals for Children re-wire cells to produce arthritis vaccine 71

Apr 19, 2017: Antibody helps detect protein implicated in Alzheimer's, other diseases 72

Apr 04, 2017: USD 3.6 million to fund personalised 3D brain maps to guide neurosurgeries 74

Jan 24, 2017: Study unveils new way to starve tumors to death 76

Product News 78

Dec 06, 2017: Alzheimer's damage in mice reduced with compound that targets APOE gene 78

Jun 19, 2018: Decades of dedication lead to drug trial for rare, fatal illness 79

Other Significant Developments 82

Sep 04, 2018: Focused delivery for brain cancers 82

Jun 19, 2018: Parent-child therapy helps young children with depression 84

Appendix 85

Methodology 85

About GlobalData 85

Contact Us 85

Disclaimer 85


List Of Figure

List of Figures

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Washington University School of Medicine, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Washington University School of Medicine, Pharmaceuticals & Healthcare, Key Facts 2

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Washington University School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Washington University School of Medicine, Deals By Therapy Area, 2012 to YTD 2018 9

Washington University School of Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine 12

Mallinckrodt Enters into Research Partnership with Washington University 13

Cerveau Technologies Enters into Agreement with Washington University School of Medicine 14

MedImmune Enters into Agreement with Washington University School of Medicine 15

LEO Pharma Enters into Agreement with Washington University School of Medicine 16

Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 17

Washington University School of Medicine, Key Competitors 18

Washington University School of Medicine, Key Employees 19

Washington University School of Medicine, Subsidiaries 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Washington University School of Medicine, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.